 Company to host conference call and webcast at 5:00 p.m. ETNEEDHAM, Mass., Aug. 03, 2020 GLOBE NEWSWIRE -- Chiasma, Inc. NASDAQ: CHMA, a commercial stage biopharmaceutical company, today announced that it will host a conference call and live audio webcast on Monday, August 10, 2020 at 5:00 p.m. Eastern Time to discuss financial results for the quarter ended June 30, 2020 and to provide a business update. Conference Call DetailsMonday, August 10th 5pm Eastern TimeDomestic:855-327-6837 International:631-891-4304 Conference ID:10010555 Webcast: A live audio webcast of the call may also be accessed under Events Presentations on the News Investors section of the Companys website, An archived replay of the webcast will be available on the Companys website approximately two hours after the event. The archived webcast will be available for one year.About ChiasmaChiasma is focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer TPE technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. On June 26, 2020, Chiasma received FDA approval of MYCAPSSA for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA is the first and only oral somatostatin analog approved by the FDA. Chiasma is headquartered in Needham, MA with a wholly owned subsidiary in Israel. MYCAPSSA, TPE and CHIASMA are registered trademarks of Chiasma. For more information, please visit the companys website at Contact: Ashley R. Robinson LifeSci Advisors, LLC 617-775-5956 Relations: Patrick Bursey LifeSci Communications 646-876-4932 